Denmark Austria temporarily suspend AstraZeneca vaccine over blood clot reports

Denmark has decided to temporarily suspend the use of the coronavirus vaccine developed by AstraZeneca and the University of Oxford due to reports of adverse blood clot reactions and a death.

The Danish Health Authority said it would temporarily stop the vaccination as a precaution “after reports of severe cases of blood clots in people who have been vaccinated with the COVID-19 vaccine from AstraZeneca.”

“Against this background, the European Medicines Agency has launched an investigation into the AstraZeneca vaccine. One report relates to a death in Denmark. At present, it cannot be concluded whether there is a link between the vaccine and the blood clots,” the health authority said in a statement.

The health authority has not specified the number of cases reported.

AstraZeneca COVID vaccine

The decision to put the vaccine on hold in Denmark and Austria will be a great setback to the already slow European vaccination campaign.

Austria, too, has announced a temporary stoppage of the vaccine beginning of this week following one person’s death and the illness of another after they got inoculated with the vaccine. Austria suspended the use of a particular batch of the drug because a woman died ten days after taking it. Estonia, Latvia, Lithuania and Luxemburg have also stopped using the batch.

Søren Brostrøm, director of the National Board of Health in Denmark, made it clear that the two-week suspension was a precaution and investigations were on.

The news has sent the shares of AstraZeneca down by 2.4% on the London Stock Exchange on Thursday.

An AstraZeneca spokesperson said that the company was aware of the temporary suspension of the vaccine by the Danish Health Authority and it is currently investigating potential adverse effects related to the vaccine.

The University of Oxford refused to comment.

The decision to put the vaccine on hold in Denmark and Austria will be a great setback to the already slow European vaccination campaign. The European Medicine Agency or EMA said its safety committee was reviewing the Austrian case, but made clear that “there is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine.”

The number of “thromboembolic events in vaccinated people is no higher than that seen in the general population”, it added.

Overall, 22 cases of thromboembolic events have been reported among the three million people vaccinated with the AstraZeneca vaccine in the European Economic Area, according to a BBC report.

Subscribe to the nation’s fastest-growing business magazine to get the latest COVID-19 vaccine news and updates.

Avatar
Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

JPMorgan earnings beat forecasts amid strengthening US economy

JPMorgan earnings beat forecasts amid strengthening US economy

JPMorgan Chase, the largest bank in America by assets reported favorable results on Wednesday, beating analysts’ estimates on trading revenue. It is the first major bank to repor
7 hours ago
Grab to take Spac route for a $40 billion listing in US

Grab to take Spac route for a $40 billion listing in US

Grab, south-east Asia’s super app that provides a wide array of services from food deliveries to digital payments is planning to list in the US through a special purpose acquisit
8 hours ago
Babcock facing writedowns of £1.7 billion, plans to cut 1000 jobs

Babcock facing writedowns of £1.7 billion, plans to cut 1000 jobs

Babcock International Group PLC, the UK defense contractor, said that a comet review for the financial year ending March 21 had identified impairments and charges totaling approxim
1 day ago
France’s water management utilities, Veolia and Suez, finally merge after long battle

France’s water management utilities, Veolia and Suez, finally merge after long battle

Veolia and arch-rival Suez, the two French waste management utility companies, have struck a deal worth nearly 13 billion euros ($15.44 billion)to merge after months of wrangling.
2 days ago
Impossible Foods mulling IPO at $10 billion valuation

Impossible Foods mulling IPO at $10 billion valuation

Impossible Foods, the makers of the widely popular plant-based burgers, plans to go public with a likely valuation of $10 billion. The vegan burger company was valued at $4 billion
2 days ago
Aramco sells minority stake to EIG Group-led consortium for $12.4 billion

Aramco sells minority stake to EIG Group-led consortium for $12.4 billion

Energy giant Saudi Aramco is selling a minority stake for 12.4-billion-dollar in a newly formed oil pipeline business to a consortium led by US-based EIG Global Energy Partners. Th
2 days ago